Daytrana Approved - Shire plc - Treatment for Attention Deficit Hyperactivity Disorder

Daytrana is a once daily transdermal patch formulation of methylphenidate indicated for the treatment of attention deficit hyperactivity disorder (ADHD).

Posted: April 2006

Related Articles:

Daytrana (methylphenidate) FDA Approval History

View comments

Hide
(web3)